TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
PBYI

Puma Biotechnology, Inc.

Healthcare · Biotechnology

9.50$ -3.4% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

Puma Biotechnology, Inc. (PBYI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 57 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size % Per share
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement PBYI
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
0.0 0.0 0.0 0.0 6.1 22 67 51 63 71 99 54 56 63 51 71 51 53 98 53 46 55 46 60 57 66 53 55 56 72 44 47 81 59 46 52 54 75 45 57 231
0.0 0.0 73 78 1.5 4.1 6.4 8.8 9.0 10 8.0 9.3 9.4 10 9.1 9.4 9.9 11 30 12 10 12 11 15 12 17 13 12 13 24 11 11 29 14 11 12 12 23 10 12 58
0.0 0.0 0.0 0.0 4.6 18 60 42 54 61 91 45 47 53 42 61 41 42 69 41 36 43 35 45 45 49 40 43 43 48 33 36 51 45 35 40 42 52 34 44 173
52 56 55 53 50 50 47 43 36 38 36 37 30 30 25 25 23 24 20 19 19 14 15 12 11 14 13 13 11 13 14 14 13 15 14 15 16 17 20 19 71
14 17 18 25 32 31 37 40 29 41 46 34 31 30 31 29 30 29 28 39 26 22 20 21 24 25 22 24 22 20 22 25 17 17 17 18 17 18 18 18 71
66 73 73 78 82 81 84 83 65 79 81 70 61 61 56 54 53 53 48 58 45 67 36 33 42 39 35 38 34 33 35 39 29 32 31 33 33 35 38 36 143
-66 -73 -73 -78 -77 -64 -23 -41 -11 -19 -10 -26 -14 -8.7 -14 7.1 -12 -11 20 -17 -9.0 -24 -0.7 12 2.4 10 4.4 4.9 8.6 15 -2.3 -2.2 22 13 4.0 6.6 9.6 17 -3.8 7.6 30
0.2 0.2 0.4 0.4 0.3 0.7 1.1 2.6 3.5 3.8 4.4 4.4 3.1 3.1 3.1 3.8 3.6 3.6 3.5 3.5 3.1 2.7 2.7 2.7 2.9 3.3 3.3 3.3 3.3 3.4 3.4 3.4 3.1 2.6 2.2 1.8 1.5 1.1 0.7 0.2 3.5
-66 -73 -73 -78 -77 -64 -24 -44 -14 -31 -10 -37 -17 -11 -17 3.4 -31 -15 17 -5.1 -45 4.4 -3.4 9.4 -0.3 -5.3 1.5 2.3 6.0 13 -4.6 -4.2 21 12 3.3 6.2 9.2 17 -3.4 8.2 31
-0.2 -0.9 -0.4 -0.4 -0.3 -0.7 1.0 2.0 1.4 -7.3 2.4 4.4 1.2 1.3 0.5 3.9 3.8 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.1 0.2 0.2 0.5 0.2 0.4 0.3 -7.1 0.3 0.3 0.4 3.7 0.3 0.1 4.5
-66 -73 -73 -78 -77 -64 -24 -44 -14 -31 -10 -37 -17 -11 -17 3.4 -31 -15 17 -5.1 -45 4.2 -3.4 9.4 -0.4 -5.6 1.4 2.1 5.8 12 -4.8 -4.5 20 19 3.0 5.9 8.8 13 -3.8 8.2 27
-66 -72 -73 -78 -76 -62 -22 -40 -8.6 -25 -3.5 -31 -12 -6.2 -12 9.4 -25 -8.3 23 1.4 -39 9.4 1.8 15 5.1 0.2 7.7 8.5 12 18 1.7 2.1 27 18 8.2 11 13 21 -0.2 14 48

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?